NCT05918835 Effects of rTMS on Food Choice in Anorexia Nervosa
| NCT ID | NCT05918835 |
| Status | Recruiting |
| Phase | — |
| Sponsor | New York State Psychiatric Institute |
| Condition | Anorexia Nervosa |
| Study Type | INTERVENTIONAL |
| Enrollment | 72 participants |
| Start Date | 2023-04-24 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 72 participants in total. It began in 2023-04-24 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will examine the impact of high-frequency repetitive transcranial magnetic stimulation on food choice behavior and related neural activity.
Eligibility Criteria
Inclusion Criteria: * DSM-5 Diagnosis of Anorexia Nervosa * Age 18-35 years * Female * Right-handed * Body Mass Index (BMI) ≥ 16.0 * Voluntarily admitted to inpatient eating disorders unit at NYSPI * Competent to provide informed consent * English-speaking * Medically stable Exclusion Criteria: * High risk of suicide * Current substance use disorder or other co- morbid psychiatric condition requiring specialized treatment (e.g., psychosis) * Diagnosis of major medical or neurological problem or taking medication that significantly increases risk for seizure or affects interpretation of findings (e.g., unstable hypertension, seizure disorder) * Food restrictions (e.g., allergies) which impact greater than 30% of food choice task's choice options * Indwelling ferromagnetic metallic object (e.g., pacemaker, pump), non- removable metal jewelry, medicinal patch or recent metallic ink tattoo * History of seizure * Diagnosis of epilepsy, stroke, multiple sclerosis, traumatic brain injury, Alzheimer's and other neurodegenerative diseases, meningoencephalitis or intracerebral abscess, or parenchymal or leptomeningeal cancers * Prior exposure to TMS * Pregnancy * Currently breast-feeding * Significant claustrophobia * Implanted devices or stimulators * Hearing loss (e.g., currently undergoing treatment with ototoxic medications or those with cochlear implants)
Contact & Investigator
Alexandra F Muratore, PhD
PRINCIPAL INVESTIGATOR
New York Sate Psychiatric Institute
Frequently Asked Questions
Who can join the NCT05918835 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 35 Years, studying Anorexia Nervosa. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05918835 currently recruiting?
Yes, NCT05918835 is actively recruiting participants. Contact the research team at afm2166@cumc.columbia.edu for enrollment information.
Where is the NCT05918835 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT05918835 clinical trial?
NCT05918835 is sponsored by New York State Psychiatric Institute. The principal investigator is Alexandra F Muratore, PhD at New York Sate Psychiatric Institute. The trial plans to enroll 72 participants.